Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients (Q84500351)
Jump to navigation
Jump to search
scientific article published on 29 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients |
scientific article published on 29 July 2011 |
Statements
Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients (English)
Mads Nybo
Simone Rørdam Preil
Henning Friis Juhl
Malene Olesen